|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0011860,
umls-concept:C0024429,
umls-concept:C0030705,
umls-concept:C0032105,
umls-concept:C0205360,
umls-concept:C0271650,
umls-concept:C0312359,
umls-concept:C0332281,
umls-concept:C0441889,
umls-concept:C0443252,
umls-concept:C1274040,
umls-concept:C1334507,
umls-concept:C1956346
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2010-12-6
|
|
pubmed:abstractText |
MIF is proatherogenic and is highly expressed in unstable atherosclerotic plaques. Circulating levels of MIF are increased in patients with impaired glucose tolerance or type 2 diabetes mellitus (IGT/T2DM). We examined whether high circulating levels of macrophage migration inhibitory factor (MIF) are related to increased risk of future coronary events in patients with coronary artery disease (CAD) and IGT/T2DM.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1879-1484
|
|
pubmed:author |
pubmed-author:FujiokaDaisukeD,
pubmed-author:HiranoMitsumasaM,
pubmed-author:KawabataKen-ichiK,
pubmed-author:KittaYoshinobuY,
pubmed-author:KobayashiTsuyoshiT,
pubmed-author:KugiyamaKiyotakaK,
pubmed-author:MakinoAritakaA,
pubmed-author:NakamuraTakamitsuT,
pubmed-author:ObataJun-eiJE,
pubmed-author:SaitoYukioY,
pubmed-author:SanoKeitaK,
pubmed-author:WatanabeKazuhiroK,
pubmed-author:WatanabeYosukeY
|
|
pubmed:copyrightInfo |
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
213
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
573-8
|
|
pubmed:meshHeading |
pubmed-meshheading:20934703-Aged,
pubmed-meshheading:20934703-Coronary Artery Disease,
pubmed-meshheading:20934703-Coronary Disease,
pubmed-meshheading:20934703-Diabetes Mellitus, Type 2,
pubmed-meshheading:20934703-Female,
pubmed-meshheading:20934703-Glucose Intolerance,
pubmed-meshheading:20934703-Humans,
pubmed-meshheading:20934703-Macrophage Migration-Inhibitory Factors,
pubmed-meshheading:20934703-Male,
pubmed-meshheading:20934703-Middle Aged,
pubmed-meshheading:20934703-Predictive Value of Tests,
pubmed-meshheading:20934703-Prognosis,
pubmed-meshheading:20934703-Prospective Studies,
pubmed-meshheading:20934703-Risk Factors
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
High plasma levels of macrophage migration inhibitory factor are associated with adverse long-term outcome in patients with stable coronary artery disease and impaired glucose tolerance or type 2 diabetes mellitus.
|
|
pubmed:affiliation |
Department of Internal Medicine II, University of Yamanashi, Faculty of Medicine, Yamanashi, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
